Merlin Capital LLC Crispr Therapeutics Ag Transaction History
Merlin Capital LLC
- $32.2 Million
- Q1 2024
A detailed history of Merlin Capital LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Merlin Capital LLC holds 8,879 shares of CRSP stock, worth $396,180. This represents 1.88% of its overall portfolio holdings.
Number of Shares
8,879
Previous 8,925
0.52%
Holding current value
$396,180
Previous $558,000
8.42%
% of portfolio
1.88%
Previous 1.64%
Shares
7 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$351 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$347 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$141 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$141 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$124 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.48B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....